enoxaparin pfs
octereotide pfs
under development

Enoxaparin PFS

Indications:

Deep vein thrombosis (DVT).

Pulmonary embolism (PE).

Unstable angina and non-ST-segment elevation myocardial infarction.

Acute ST-segment elevation myocardial infarction (STEMI).

Brand Name:

Ghemaxan, Hepaxane, Gemapaxane.

Administration form:

Injectable PFS (Pre-filled Syringes) administration.

Status:

Global distribution with multi-market regulatory compliance.

ghemaxan

Octreotide PFS

Indications:

Long-term treatment of acromegaly.

Manage symptoms and control tumor growth in carcinoid tumors and gastrinomas.

Symptomatic treatment of hormonal and secretory gastrointestinal disorders.

Brand Name:

Siroctid, Treoject.

Administration form:

Injectable PFS (Pre-filled Syringes) administration.

Strenghts:

50mcg/mL, 100mcg/mL, 500mcg/mL.

Status:

Global distribution with multi-market regulatory compliance.

The only immediate-release formulation in PFS worldwide.

octereotide pfs - treoject

Glatiramer PFS

Indications:

Treatment of relapsing forms of multiple sclerosis (MS).

Reduces the frequency and severity of MS relapses.

Modulates the immune system to decrease autoimmune attacks on the nervous system.

Brand Name:

Glatiramer.

Administration form:

Injectable PFS (Pre-filled Syringes).

Strenghts:

20mg/mL, 40mg/mL.

Status:

US approved, commercial launch upcoming.

Glatiramer pfs - treoject